|
⚲
|
| Keyboard |
| Three Arch Capital LP
✚
|
|
|---|---|
| CIK # | 0001131056 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001131056] | |
| 4 | [0001131056] | |
| SC 13G | [0001131056] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Three Arch Capital LP | Liposcience Inc | [2014-02-13] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Liposcience Inc | |
| Jaeger Wilfred E | |
| Wan Mark A | |
| TAC Management LLC | |
| Three Arch Capital LP | |
| TAC Associates LP |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Liposcience Inc LPDX
Common Stock
|
2013-01-30 | Buy | 9,705 | $9.00 | 87,345 |
|
Liposcience Inc LPDX
Common Stock
|
2013-01-30 | Conversion | 1,536,688 | ||
|
Liposcience Inc LPDX
Common Stock
|
2013-01-30 | Buy | 205,295 | $9.00 | 1,847,655 |
|
Liposcience Inc LPDX
Common Stock
|
2013-01-30 | Conversion | 72,646 | ||
|
Liposcience Inc LPDX
Series D-1 Convertible Preferred Stock · derivative
|
2013-01-30 | Conversion | 69,183 | $0.00 | |
|
Liposcience Inc LPDX
Series F Convertible Preferred Stock · derivative
|
2013-01-30 | Conversion | 534,339 | $0.00 | |
|
Liposcience Inc LPDX
Series E Convertible Preferred Stock · derivative
|
2013-01-30 | Conversion | 41,509 | $0.00 | |
|
Liposcience Inc LPDX
Series E Convertible Preferred Stock · derivative
|
2013-01-30 | Conversion | 878,030 | $0.00 | |
|
Liposcience Inc LPDX
Series D-1 Convertible Preferred Stock · derivative
|
2013-01-30 | Conversion | 1,463,385 | $0.00 | |
|
Liposcience Inc LPDX
Series F Convertible Preferred Stock · derivative
|
2013-01-30 | Conversion | 25,261 | $0.00 |